Ceftazidime Hikma Farmacêutica (Portugal)

Ceftazidime Hikma Farmacêutica (Portugal) is an antibiotic medication used to treat bacterial infections. This broad-spectrum cephalosporin is effective against various gram-negative bacteria, including those resistant to other antibiotics.

Ceftazidime is primarily used to treat severe bacterial infections, including those affecting the lungs, urinary tract, and bloodstream. It is often prescribed for infections caused by gram-negative bacteria, which are resistant to other antibiotics. Ceftazidime is administered via intramuscular or intravenous routes, making it suitable for both hospital and outpatient settings.

Common effects of Ceftazidime may include mild to moderate reactions at the injection site, such as redness or swelling. Some individuals may experience gastrointestinal discomfort, including nausea or diarrhea. Severe allergic reactions are rare but require immediate medical attention.

Ceftazidime should be used with caution in individuals with a history of allergic reactions to cephalosporins or penicillin. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Always follow the prescribed dosage and administration instructions provided by your healthcare professional.

Ceftazidime may interact with certain medications, including other antibiotics and drugs that affect kidney function. It is advisable to avoid alcohol while taking Ceftazidime, as it may increase the risk of side effects. Always consult your healthcare provider before starting any new medication while on Ceftazidime.